phase 1_initiation
saveCity of Hope — CHOP [cyclophosphamide + doxorubicin + vincristine + prednisolone] (Phase I Trial Initiation)
community read0 votes
Therapy area: Oncology. Indication: Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, Follicular Lymphoma, Natural Killer Cell Lymphomas, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphomas (PTCL), T-Cell Lymphomas
Data sources
globaldata
Found something off?
same company · ±60 days · 5
- phase 2 resultsMaxtrex: City of Hope — Methotrexate Teva (Phase II Trial Results)Apr 24, 2026
- grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Role and regulation of methylarginine effector TDRD3 in T cell immunityApr 8, 2026
- grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — A novel pentavalent circular RNA-based EBV vaccineApr 1, 2026
- grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — An exosome-based liquid biopsy assay for the non-invasive early detection of ...Mar 16, 2026
- grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — The Novel Role and Mechanism of RBM33 in LeukemogenesisMar 1, 2026
related news · 3
🐶 often sniffed alongside
top 8- drugdoxorubicin1 co-mentions · 1 sources
- companyCity of Hope1 co-mentions · 1 sources
- tagOncology1 co-mentions · 1 sources
- tagDLBCL1 co-mentions · 1 sources
- drugcyclophosphamide1 co-mentions · 1 sources
- drugprednisolone1 co-mentions · 1 sources
- drugDoxorubicin Teva1 co-mentions · 1 sources
- drugFarmiblastina1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that